在阿尔茨海默氏症痴呆症中探索睡眠障碍的潜在机制:一个全面的审查
1Health and Social Care, University of South Wales, Norwich, GBR.
Cureus
|February 4, 2025
概括
睡眠障碍与阿尔茨海默氏症痴呆症 (AD) 联系在一起,通过共同的遗传学,大脑变化和炎症. 解决睡眠问题可能是AD管理的早期治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 睡眠医学 睡眠医学
背景情况:
- 阿尔茨海默氏症痴呆症 (AD) 涉及认知能力下降和非认知症状,如睡眠障碍 (SD).
- 睡眠对大脑功能至关重要,包括记忆,突触可塑性和废物清除.
- 连接AD和SD的机制尚未完全理解.
研究的目的:
- 探索连接阿尔茨海默氏症痴呆和睡眠障碍的机制.
- 评估这些机制对AD管理的临床相关性.
主要方法:
- 使用诸如"阿尔茨海默氏症和睡眠障碍"等关键词进行系统的文献搜索.
- 分析了1511个已识别的记录,其中18个被纳入最终审查.
主要成果:
- 确定了几个连接AD和SD的机制,表明了双向关系.
- 关键的机制包括共享的遗传,干扰的淋巴和昼夜系统,神经炎症,改变的大脑连接和区域大脑缩.
- 睡眠障碍可以在AD发病之前出现,并且随着疾病的进展而恶化.
结论:
- AD和SD之间的关系是复杂的,双向的.
- 睡眠可能成为阿尔茨海默氏症痴呆症的潜在生物标志物.
- 针对睡眠障碍可能是管理AD的早期治疗策略.
相关概念视频
Sleep-Wake Cycles
3.4K
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
3.4K
Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Sedatives and Hypnotics Drugs: Miscellaneous Agents
939
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
939
Sleepwalking and Sleep Talking
1.6K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.6K
REM Sleep Behavior Disorder
2.7K
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
2.7K


